Literature DB >> 12587674

Muscle reinnervation and IGF-I synthesis are affected by exposure to heparin: an effect partially antagonized by anti-growth hormone-releasing hormone.

Laura Madaschi1, Anna Maria Di Giulio, Alfredo Gorio.   

Abstract

Sciatic nerve crush was performed in 2-day-old rats, then reinnervation of the extensor digitorum longus muscle, motor neuron survival, and muscle IGF-I production were monitored. In saline-treated rats, the extent of reinnervation was around 50% and the number of EDL reinnervating motor neurons was significantly reduced. In heparin-treated rats the extent of muscle reinnervation, the recovery of nerve-evoked muscle twitch tension, and the number of motor neurons reinnervating the extensor digitorum longus muscle were greatly enhanced compared to saline-treated rats. In addition, treatment with heparin increased markedly insulin-like growth factor-I levels in denervated muscles. The concomitant exposure to anti-growth hormone releasing hormone partially abolished the stimulatory action of heparin on muscle reinnervation and prevented the increase of insulin-like growth factor-I muscle levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12587674     DOI: 10.1023/a:1021616716463

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  49 in total

Review 1.  Growth factors in the extracellular matrix.

Authors:  J Taipale; J Keski-Oja
Journal:  FASEB J       Date:  1997-01       Impact factor: 5.191

2.  Changes in glycosaminoglycans during regeneration of post-crush sciatic nerves of adult guinea pigs.

Authors:  D K Shum; C H Chau
Journal:  J Neurosci Res       Date:  1996-11-15       Impact factor: 4.164

3.  Neuronal proteoglycans: biosynthesis and functional interaction with neurons in vitro.

Authors:  K E Dow; S E Mirski; J C Roder; R J Riopelle
Journal:  J Neurosci       Date:  1988-09       Impact factor: 6.167

4.  Permanent changes in muscle and motoneurones induced by nerve injury during a critical period of development of the rat.

Authors:  M B Lowrie; S Krishnan; G Vrbová
Journal:  Brain Res       Date:  1987-01       Impact factor: 3.252

5.  Insulin-like growth factors act synergistically with basic fibroblast growth factor and nerve growth factor to promote chromaffin cell proliferation.

Authors:  M Frödin; S Gammeltoft
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

6.  Nerve regeneration and serum levels of insulin-like growth factor-I in rats with streptozotocin-induced insulin deficiency.

Authors:  A R Ekström; M Kanje; A Skottner
Journal:  Brain Res       Date:  1989-09-04       Impact factor: 3.252

7.  Co-administration of IGF-I and glycosaminoglycans greatly delays motor neurone disease and affects IGF-I expression in the wobbler mouse: a long-term study.

Authors:  Alfredo Gorio; Elena Lesma; Laura Madaschi; Anna Maria Di Giulio
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

Review 8.  Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: novel non-anticoagulant action of glycosaminoglycans.

Authors:  A Gorio; L Vergani; E Lesma; A M Di Giulio
Journal:  J Neurosci Res       Date:  1998-03-01       Impact factor: 4.164

9.  Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

10.  Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse.

Authors:  L Vergani; M Losa; E Lesma; A M Di Giulio; A Torsello; E E Müller; A Gorio
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

View more
  1 in total

Review 1.  Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury.

Authors:  Benjamin R Slavin; Karim A Sarhane; Nicholas von Guionneau; Phillip J Hanwright; Chenhu Qiu; Hai-Quan Mao; Ahmet Höke; Sami H Tuffaha
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.